DataMEDS AI Inc.
MEDS | NASDAQ
$1.88
-$0.04 (-2.08%)
Nov 2, 2026, 12:31 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 8.02M | 14.03M | 23.34M | 34.08M | 36.74M | 39.38M | 36.46M | 58.42M | 52.75M | 42.31M | 34.37M | n/a | n/a |
Cost of Revenue | 18.06M | 23.39M | 32.17M | 32.05M | 34.88M | 36.64M | 33.59M | 53.38M | 47.76M | 38.72M | 31.6M | n/a | n/a |
Gross Profit | -10.04M | -9.36M | -8.83M | 2.03M | 1.85M | 2.75M | 2.87M | 5.05M | 4.99M | 3.59M | 2.77M | n/a | n/a |
Operating Income | -57.71M | -55.86M | -81.19M | -72.14M | -42.34M | -39.13M | -9.26M | -15.83M | -14.99M | -13.13M | -11.65M | -1.33M | -428.76K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -88.28M | -76.59M | -101.27M | -77.75M | -45.3M | -41.01M | -10.36M | -17.82M | -16.86M | -14.9M | -13.13M | -1.33M | -428.76K |
Net Income | -88.28M | -76.59M | -101.27M | -77.75M | -45.3M | -41.01M | -10.36M | -17.82M | -16.86M | -14.9M | -13.13M | -1.33M | -428.76K |
Selling & General & Admin | 48.12M | 46.15M | 71.56M | 71.77M | 42.59M | 39.22M | 9.82M | 13.77M | 12.87M | 11.47M | 9.63M | 1.33M | 428.76K |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | -446.05K | 356.75K | 802.79K | 2.41M | 1.61M | 2.66M | 2.32M | 7.11M | 7.11M | 5.26M | 4.79M | n/a | n/a |
Operating Expenses | 47.67M | 46.5M | 72.36M | 74.18M | 44.19M | 41.87M | 12.14M | 20.88M | 19.98M | 16.73M | 14.42M | 1.33M | 428.76K |
Interest Expense | 5.93M | 5.56M | 4.58M | 4.39M | 3.11M | 2.44M | 1.64M | 2.53M | 2.4M | 1.88M | 1.58M | n/a | n/a |
Selling & Marketing Expenses | 1.89M | 2.12M | 1.22M | 1.21M | 408.6K | 65.22K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 65.73M | 69.9M | 104.53M | 106.22M | 79.08M | 78.51M | 45.72M | 74.25M | 67.74M | 55.44M | 46.02M | 1.33M | 428.76K |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 2.57M | 2.09M | 1.42M | 1.49M | 1.24M | 1.04M | 1.04M | 1.04M | 1.04M | 977.29K | 935.84K | 1.04M | 1.04M |
Shares Outstanding (Diluted) | 2.57M | 2.09M | 1.42M | 1.49M | 1.24M | 1.04M | 1.04M | 1.04M | 1.04M | 977.29K | 935.84K | 1.04M | 1.04M |
EPS (Basic) | -47.13 | -45.50 | -73 | -63.67 | -42.47 | -37.52 | -8.34 | -16.77 | -15.84 | -15.69 | -13.88 | -1.28 | -0.41 |
EPS (Diluted) | -47.13 | -45.50 | -73 | -63.67 | -42.47 | -37.52 | -8.34 | -16.77 | -15.84 | -15.69 | -13.88 | -1.28 | -0.41 |
EBITDA | -56.41M | -54.11M | -79.33M | -70.41M | -39.61M | -34.94M | -5.41M | -7.74M | -7.35M | -7.77M | -6.76M | -1.33M | -428.76K |
EBIT | -58.73M | -56.87M | -82.54M | -73.47M | -42.32M | -38.69M | -8.83M | -15.3M | -14.46M | -13.03M | -11.55M | -1.33M | -428.76K |
Depreciation & Amortization | 2.32M | 2.77M | 3.21M | 3.06M | 2.71M | 3.76M | 3.42M | 7.57M | 7.11M | 5.26M | 4.79M | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MEDS